Aude Le Roy

477 total citations
11 papers, 219 citations indexed

About

Aude Le Roy is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Aude Le Roy has authored 11 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Aude Le Roy's work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (5 papers). Aude Le Roy is often cited by papers focused on Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (5 papers). Aude Le Roy collaborates with scholars based in France and United States. Aude Le Roy's co-authors include Daniel Olive, Norbert Vey, Anne-Sophie Chrétien, Cyril Fauriat, Didier Blaise, Thomas Prébet, Florence Orlanducci, Rémy Castellano, A. Benyamine and Céline Castanier and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Aude Le Roy

11 papers receiving 217 citations

Peers

Aude Le Roy

IMMUN

ONCOL

HEMAT

RNMI

Joseph Wahle United States

Meixin Shen Singapore

Xueyu Hong China

Beate Hauptrock Germany

Claudia Brehm Germany

Mina Sandusky Germany

Lorenz Jahn Netherlands

Dan Fu Ruan United States

Lukas Amon Germany

Judith C. Kaiser United States

Joseph Wahle United States

Aude Le Roy

216 ×1.2

IMMUN

48 ×0.4

ONCOL

41 ×1.2

52 ×1.6

HEMAT

5 ×0.5

RNMI

Citations per year, relative to Aude Le Roy Aude Le Roy (= 1×) peers Joseph Wahle

Countries citing papers authored by Aude Le Roy

Since Specialization

Citations

This map shows the geographic impact of Aude Le Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aude Le Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aude Le Roy more than expected).

Fields of papers citing papers by Aude Le Roy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aude Le Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aude Le Roy. The network helps show where Aude Le Roy may publish in the future.

Co-authorship network of co-authors of Aude Le Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Aude Le Roy. A scholar is included among the top collaborators of Aude Le Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aude Le Roy. Aude Le Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Imbert, Caroline, Nicolas Boucherit, Laurent Gorvel, et al.. (2024). Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis. Cancer Immunology Research. 12(12). 1677–1690. 3 indexed citations

Orlanducci, Florence, Marie C. Béné, Amira Ben Amara, et al.. (2024). Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood Advances. 8(16). 4262–4275. 2 indexed citations

Gorvel, Laurent, et al.. (2022). Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer. Cancer Research. 82(21). 3868–3879. 21 indexed citations

Imbert, Caroline, Aude De Gassart, Florence Orlanducci, et al.. (2021). Targeting BTN2A1 By a Unique Activating Mab Improves Vγ9Vδ2 T Cell Cytotoxicity Against Primary Acute Lymphoblastic Blasts. Blood. 138(Supplement 1). 2302–2302. 2 indexed citations

Marie‐Cardine, Anne, Aude Le Roy, Jérôme Giustiniani, et al.. (2021). 857 Selective Treg depletion in solid tumors with ALD2510, a novel humanized CD25-specific, IL-2 sparing monoclonal antibody. SHILAP Revista de lepidopterología. A898–A898. 4 indexed citations

Orlanducci, Florence, Antoine Briantais, Aude Le Roy, et al.. (2019). Anti-BTN3A 20.1 Agonist Monoclonal Antibody Enhances Autologous Vγ9Vδ2 T Cells Cytotoxicity Against Primary Acute Myeloid Blasts. Blood. 134(Supplement_1). 5153–5153. 3 indexed citations

Roy, Aude Le, Thomas Prébet, Rémy Castellano, et al.. (2018). Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities. Frontiers in Immunology. 9. 977–977. 24 indexed citations

Roy, Aude Le, Caroline Soulas, Benjamín Rossi, et al.. (2018). Abstract 2713: Preclinical development of first-in-class antibodies targeting Siglec-9 immune checkpoint for cancer immunotherapy. Cancer Research. 78(13_Supplement). 2713–2713. 10 indexed citations

Chrétien, Anne-Sophie, Raynier Devillier, Cyril Fauriat, et al.. (2017). NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML. OncoImmunology. 6(12). e1307491–e1307491. 40 indexed citations

10.

Benyamine, A., Aude Le Roy, Émilie Mamessier, et al.. (2016). BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia. OncoImmunology. 5(10). e1146843–e1146843. 43 indexed citations

11.

Chrétien, Anne-Sophie, Aude Le Roy, Norbert Vey, et al.. (2014). Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity. Frontiers in Immunology. 5. 122–122. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact